학술논문
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial
Document Type
Article
Author
Source
In The Lancet Oncology April 2020 21(4):541-550
Subject
Language
ISSN
1470-2045